GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » NetraMark Holdings Inc (OTCPK:AINMF) » Definitions » Short-Term Debt

AINMF (NetraMark Holdings) Short-Term Debt : $0.00 Mil (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is NetraMark Holdings Short-Term Debt?

NetraMark Holdings's Short-Term Debt for the quarter that ended in Jun. 2024 was $0.00 Mil.

NetraMark Holdings Short-Term Debt Historical Data

The historical data trend for NetraMark Holdings's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NetraMark Holdings Short-Term Debt Chart

NetraMark Holdings Annual Data
Trend Sep20 Sep21 Sep22 Sep23
Short-Term Debt
- - - -

NetraMark Holdings Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

NetraMark Holdings Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

NetraMark Holdings Short-Term Debt Related Terms

Thank you for viewing the detailed overview of NetraMark Holdings's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

NetraMark Holdings Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » NetraMark Holdings Inc (OTCPK:AINMF) » Definitions » Short-Term Debt
Comparable Companies
TSXV:THNK XCNQ:HS TSXV:ADK TSXV:NEWU TSXV:DOC TSXV:NURS TSXV:CDX XCNQ:CGN TSXV:XYBN XCNQ:UDOC GEHC VEEV TSE:2413 HQY ASX:PME RCM TXG DOCS PGNY TDOC
Traded in Other Exchanges
AIAI:Canada
Address
1655 Dupont Street, Suite 101, Toronto, ON, CAN, M6P 3T1
Website
https://www.netramark.com
NetraMark Holdings Inc is focused on the application of an Artificial Intelligence (AI) / Machine Learning (ML) solution targeted at the pharmaceutical industry in order to de-risk clinical trials. NetraMark has a proprietary technology that is capable of cutting through the combinatorial complexity that comes with dealing with heterogeneous patient populations to extract precisely defined personas of patients with respect to placebo and drug response, in addition to tolerability and adverse events. By using the client's own contemporaneous data, and having the capacity to learn from small data, the NetraAI tech extracts these personas to equip pharmaceutical companies with strategies to optimize their next trials for success.